High-dimensional mass cytometry analysis of NK cell alterations in Acute Myeloid Leukemia identifies a subgroup with adverse clinical outcome
View ORCID ProfileAnne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, Charlotte Cordier, Clemence Demerle, Nassim Salem, Julia Wlosik, Florence Orlanducci, Emilie Gregori, Magali Paul, Philippe Rochigneux, Thomas Pagliardini, Mathieu Morey, Cyril Fauriat, Nicolas Dulphy, Antoine Toubert, Herve Luche, Marie Malissen, Didier Blaise, Jacques A. Nunès, Norbert Vey, Daniel Olive
doi: https://doi.org/10.1101/2020.10.01.20204867
Anne-Sophie Chretien
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
Raynier Devillier
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
3Hematology Department, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France
Samuel Granjeaud
4Systems Biology Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France
Charlotte Cordier
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
5Biopathology Department, Institut Paoli-Calmettes, Marseille, France
Clemence Demerle
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
Nassim Salem
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
Julia Wlosik
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
Florence Orlanducci
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
Emilie Gregori
6Centre d’Immunophénomique–Luminy (Ciphe), Inserm US012, CNRS UMS3367, Aix-Marseille University, Marseille, France
Magali Paul
7ImCheck therapeutics, Marseille, France
Philippe Rochigneux
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
8Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France
Thomas Pagliardini
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
3Hematology Department, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France
Mathieu Morey
9Datactivist, Aix-en-Provence, France
Cyril Fauriat
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
Nicolas Dulphy
10Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie, Immunology and Histocompatibility department, Hôpital Saint-Louis, APHP, Inserm UMRS-1160, Paris, France
Antoine Toubert
10Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie, Immunology and Histocompatibility department, Hôpital Saint-Louis, APHP, Inserm UMRS-1160, Paris, France
Herve Luche
6Centre d’Immunophénomique–Luminy (Ciphe), Inserm US012, CNRS UMS3367, Aix-Marseille University, Marseille, France
Marie Malissen
6Centre d’Immunophénomique–Luminy (Ciphe), Inserm US012, CNRS UMS3367, Aix-Marseille University, Marseille, France
11Centre d’Immunologie de Marseille-Luminy (CIML), Inserm CNRS, Aix-Marseille University, Marseille, France
Didier Blaise
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
3Hematology Department, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France
Jacques A. Nunès
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
Norbert Vey
3Hematology Department, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France
Daniel Olive
1Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Marseille, France
2Immunomonitoring department, Institut Paoli-Calmettes, Marseille, France
- supplementary data[supplements/204867_file02.pdf]
Posted October 02, 2020.
High-dimensional mass cytometry analysis of NK cell alterations in Acute Myeloid Leukemia identifies a subgroup with adverse clinical outcome
Anne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, Charlotte Cordier, Clemence Demerle, Nassim Salem, Julia Wlosik, Florence Orlanducci, Emilie Gregori, Magali Paul, Philippe Rochigneux, Thomas Pagliardini, Mathieu Morey, Cyril Fauriat, Nicolas Dulphy, Antoine Toubert, Herve Luche, Marie Malissen, Didier Blaise, Jacques A. Nunès, Norbert Vey, Daniel Olive
medRxiv 2020.10.01.20204867; doi: https://doi.org/10.1101/2020.10.01.20204867
High-dimensional mass cytometry analysis of NK cell alterations in Acute Myeloid Leukemia identifies a subgroup with adverse clinical outcome
Anne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, Charlotte Cordier, Clemence Demerle, Nassim Salem, Julia Wlosik, Florence Orlanducci, Emilie Gregori, Magali Paul, Philippe Rochigneux, Thomas Pagliardini, Mathieu Morey, Cyril Fauriat, Nicolas Dulphy, Antoine Toubert, Herve Luche, Marie Malissen, Didier Blaise, Jacques A. Nunès, Norbert Vey, Daniel Olive
medRxiv 2020.10.01.20204867; doi: https://doi.org/10.1101/2020.10.01.20204867
Subject Area
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (725)
- Anesthesia (214)
- Cardiovascular Medicine (3085)
- Dermatology (260)
- Emergency Medicine (462)
- Epidemiology (13014)
- Forensic Medicine (13)
- Gastroenterology (860)
- Genetic and Genomic Medicine (4833)
- Geriatric Medicine (445)
- Health Economics (750)
- Health Informatics (3054)
- Health Policy (1101)
- Hematology (407)
- HIV/AIDS (956)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (499)
- Neurology (4602)
- Nursing (244)
- Nutrition (683)
- Oncology (2385)
- Ophthalmology (673)
- Orthopedics (268)
- Otolaryngology (333)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1238)
- Primary Care Research (519)
- Public and Global Health (7186)
- Radiology and Imaging (1601)
- Respiratory Medicine (943)
- Rheumatology (459)
- Sports Medicine (403)
- Surgery (509)
- Toxicology (65)
- Transplantation (220)
- Urology (188)